Document Detail

Indications for treatment of silent myocardial ischemia.
MedLine Citation:
PMID:  3154696     Owner:  NLM     Status:  MEDLINE    
A rational approach to treatment of silent myocardial ischemia is based on an appreciation of those factors influencing prognosis in the three types of patients that clinicians see with this disorder: those who are totally asymptomatic (type 1), those who are asymptomatic following myocardial infarction (type 2), and those who have angina and silent myocardial ischemia (type 3). Prognosis in type 1 and type 2 patients is generally good, except when triple vessel or left main disease is present. Risk factor modification and anti-ischemic medication should be employed in these patients, with serious consideration given to revascularization procedures. The latter approach is less controversial in type 3 patients who have frequent episodes of silent myocardial ischemia, especially if high dose anti-ischemic agents fail.
P F Cohn
Related Documents :
7059056 - Effect of fentanyl on myocardial metabolism during ischemia.
24685326 - Meta-analysis of outcomes after intravascular ultrasound-guided versus angiography-guid...
24562806 - Relationship between st-segment resolution and anterior infarct size after primary perc...
8725526 - Electrocochleography during experimental cochlear ischemia of the guinea pig.
6998456 - Acceleration forces on the human subject.
366826 - Phonocardiographic recording of heterotopic cardiac graft function in the rat. i. diagn...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy     Volume:  2     ISSN:  0920-3206     ISO Abbreviation:  Cardiovasc Drugs Ther     Publication Date:  1988 May 
Date Detail:
Created Date:  1991-04-26     Completed Date:  1991-04-26     Revised Date:  2005-11-16    
Medline Journal Info:
Nlm Unique ID:  8712220     Medline TA:  Cardiovasc Drugs Ther     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  67-9     Citation Subset:  IM    
Department of Medicine, State University of New York Health Sciences Center, Stony Brook 11794.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Coronary Disease / drug therapy*,  physiopathology

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Silent ischemia: a relevant problem in patients with coronary artery disease?
Next Document:  Nonresponsiveness to antianginal therapy--a frequent problem?